Pharma Marketing Network
APRIL 20, 2025
Introduction In todays fast-evolving healthcare environment, one truth has become increasingly clear: Healthcare Branding is no longer just about recognition; it’s about trust, authenticity, and relevance. As the healthcare sector shifts under the weight of new technologies, regulatory changes, and consumer demands, branding strategies that worked a decade ago are becoming obsolete.
Pharmacy Times
APRIL 20, 2025
Philip Kuball, MD, neurology resident at NYU Langone Health, highlights the integral role of pharmacists in monitoring patient eligibility, managing dosing schedules, and ensuring safe medication interactions for lecanemab treatment in Alzheimer disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 20, 2025
Introduction Is Big Pharma a villainous label or a misunderstood brand? In todays complex healthcare ecosystem, the term Big Pharma has become both a cultural catchphrase and a marketing dilemma. While the pharmaceutical industry continues to drive innovation, the public perception often skews negative. For marketers in 2025, understanding the implications of this term is more important than ever.
Pharmacy Joe
APRIL 20, 2025
In this episode, Ill discuss whether the composition of the first few liters of resuscitation fluid is most important for patients with sepsis. Episode 1019: Normal Saline Vs. Balanced Crystalloids Could the First Few Liters Be the Ones That Matter Most? Despite the biological plausibility that using balanced crystalloid solutions for resuscitation in sepsis over normal saline should result in better outcomes due to less hyperchloremic acidosis, results from trials looking at this issue have be
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma Marketing Network
APRIL 20, 2025
The question of Survival Rates for AIDS remains one of the most pressing concerns for patients, families, and clinicians alike. While AIDS was once synonymous with a death sentence, the narrative in 2025 tells a different storyone of progress, persistence, and possibility. But what do the numbers say today? And how does modern medicine impact outcomes?
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
APRIL 20, 2025
The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron’s blockbuster drug Dupixent for patients with a type of skin condition, the two companies said on Friday. The agency’s green light is a victory for the companies, as the FDA had declined to approve the drug for the skin condition in 2023 and had sought more efficacy data.
Med Ed 101
APRIL 20, 2025
Test Your Knowledge on Atrial Fibrillation For healthcare professionals and students, understanding atrial fibrillation (AFib) is essential. As the most common sustained cardiac arrhythmia, AFib presents frequently in clinical settings and requires a solid grasp of pathophysiology, diagnostic criteria, and management strategies. To make mastering this critical topic more engaging, weve created a free atrial […] The post Sharpen Your Clinical Skills with Our Atrial Fibrillation Crossword Pu
Pharmacy Joe
APRIL 20, 2025
In this episode, Ill discuss whether the composition of the first few liters of resuscitation fluid is most important for patients with sepsis. Episode 1019: Normal Saline Vs. Balanced Crystalloids Could the First Few Liters Be the Ones That Matter Most? Despite the biological plausibility that using balanced crystalloid solutions for resuscitation in sepsis over normal saline should result in better outcomes due to less hyperchloremic acidosis, results from trials looking at this issue have be
FDA Law Blog: Biosimilars
APRIL 20, 2025
By Dr. Naomi Lowy, Principal Drug Regulatory Expert & James E. Valentine There is much change happening at FDA. In the wake of the April 1 st reduction in force, there has been a great deal of uncertainty about what the impacts will be. This rings particularly true amongst the rare disease patient community, along with many small biotech companies (and their investors) that take on the risk of developing orphan drugs for exceedingly small patient populations.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Expert insights. Personalized for you.
59 
Let's personalize your content